Post-therapy viral set-point abatement following combined antiproliferative and immune-boosting interventions: results from a randomised clinical trial

• R. Sobhie Diaz,
• L.B. Giron,
• J. Galinskas,
• J. Hunter,
• M. Janini,
• I.L. Shytaj,
• R. Cauda,
• M.C. Sucupira,
• J. Maricato,
• A. Savarino

Affiliations

R. Sobhie Diaz

Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, Brazil

L.B. Giron

Wistar Institute, Philadelphia, USA

J. Galinskas

Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, Brazil

J. Hunter

Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, Brazil

M. Janini

Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, Brazil

I.L. Shytaj

Heidelberg University Hospital, Department of Infectious Diseases, Heidelberg, Germany

R. Cauda

Institute of Infectious Diseases, Gemelli Hospital, Catholic University of Sacred Heart, Rome, Italy

M.C. Sucupira

Federal University of Sao Paulo, Infectious Diseases Department, Sao Paulo, Brazil

J. Maricato

Federal University of Sao Paulo, Infectious Diseases Department, Sao Paulo, Brazil

A. Savarino

Department of Infectious Diseases, Italian Institute of Health, Rome, Italy